Japanese drug for COVID-19 arrives in Sri Lanka

Japanese drug for COVID-19 arrives in Sri Lanka

March 31, 2020   04:12 pm

-

Experts in Sri Lanka are about to launch research into the Japanese drug which has been found to be useful in reducing the complications of the COVID-19 virus.

Chairman of the State Pharmaceutical Corporation (SPC) Dr. Prasanna Gunasena said that this will be coordinated with the intervention of the National Drug Regulatory Commission.

The stock of relevant drug which was ordered from Japan was shipped into the country yesterday (30).

However, it has not been established whether the drug can be used for coronavirus infected patients and it is still under research-level, said Dr. Gunasena.


Previously, Japan’s health minister said the government was considering using a drug called Avigan, also known as favipiravir, to treat patients sickened by COVID-19.

More than a month later, favipiravir has shown promise in two trials involving coronavirus patients, with more countries, all desperate for an answer to COVID-19, prepare to test its effectiveness, reports foreign media.

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories